|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/09 | (2006.01) |
| A61K 38/00 | (2006.01) | ||
| A61K 38/17 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61P 7/02 | (2006.01) | ||
| A61P 7/06 | (2006.01) | ||
| A61P 9/12 | (2006.01) | ||
| A61P 11/00 | (2006.01) | ||
| A61P 11/06 | (2006.01) | ||
| A61P 13/12 | (2006.01) | ||
| A61P 19/02 | (2006.01) | ||
| A61P 21/04 | (2006.01) | ||
| A61P 25/28 | (2006.01) | ||
| A61P 29/00 | (2006.01) | ||
| A61P 31/04 | (2006.01) | ||
| A61P 31/18 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61P 37/00 | (2006.01) | ||
| A61P 37/02 | (2006.01) | ||
| A61P 37/06 | (2006.01) | ||
| A61P 43/00 | (2006.01) | ||
| C07K 14/705 | (2006.01) | ||
| C07K 14/715 | (2006.01) | ||
| C07K 16/28 | (2006.01) | ||
| C07K 19/00 | (2006.01) | ||
| C12N 1/15 | (2006.01) | ||
| C12N 1/19 | (2006.01) | ||
| C12N 1/21 | (2006.01) | ||
| C12N 5/10 | (2006.01) | ||
| C12P 21/02 | (2006.01) | ||
| C12P 21/08 | (2006.01) |
| (11) | Number of the document | 1141274 |
| (13) | Kind of document | T |
| (96) | European patent application number | 00902354.0 |
| Date of filing the European patent application | 2000-01-07 | |
| (97) | Date of publication of the European application | 2001-10-10 |
| (45) | Date of publication and mention of the grant of the patent | 2003-09-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US0000/396 |
| Date | 2000-01-07 |
| (87) | Number | WO 0004/0716 |
| Date | 2000-07-13 |
| (30) | Number | Date | Country code |
| 226533 | 1999-01-07 | US |
| (72) |
GROSS, Jane, A., US
XU, Wenfeng, US
MADDEN, Karen, US
YEE, David, P., US
|
| (73) |
ZymoGenetics, Inc.,
1201 Eastlake Avenue East, Seattle, WA 98102,
US
|
| (54) | SOLUBLE RECEPTOR BR43X2 AND METHODS OF USING THEM FOR THERAPY |
| SOLUBLE RECEPTOR BR43X2 AND METHODS OF USING THEM FOR THERAPY |